-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Dilution, Not Bankruptcy, Is the Key Risk Facing Aurora Cannabis Stock
Aurora stock continues to fall, and its risk seems to be accelerating. But the imminent risk is more issuance of ACB stock, not bankruptcy.
Expect More Dilution, Debt, Deficits, and a Deep Drop in ACB Stock
Expect more dilution, debt, deficits, and a deep drop in Aurora stock. Aurora Cannabis free cash flow losses will require more debt and dilution.
Best ETFs for 2020: The Alternative Harvest ETF (MJ) Will Light Up
The Alternative Harvest ETF (MJ) has a shot at being one of the best ETFs next year, as its holdings should bounce off their all-time lows.
3 Excellent Reasons to Be Bullish on Aphria
It’s been horrific for cannabis stocks. But Aphria stock is presenting some interesting opportunities. Here’s a look at this standout company.
Hexo? Heck No! Just Avoid Hexo Stock for Now
I'm still bullish on marijuana stocks, but I won't let Hexo stock weigh down my portfolio.
Tuesday’s Vital Data: Freeport-McMoRan, Canopy Growth and Aurora Cannabis
Options trading was buzzing in Freeport-McMoRan, Canopy Growth and Aurora Cannabis. Here are the metrics that matter moving forward.
Aphria Is Making the Right Moves to Survive Marijuana Slump
The outlook for cannabis stocks remains challenging. But if anyone can turn it around in 2020, it could well be Aphria.
If You Haven’t Ditched NBEV Stock Yet, Now Is the Time
New Age Beverages stock is a multi-level marketing loser. The CEO is selling shares and the company is in debt and losing money.
5 Reasons to Buy Aphria Stock Before Pot Stocks Start Moving Again
Like other Canadian cannabis stocks, APHA stock has taken a beating in recent months as revenue growth has fallen short of expectations. However, there are at least five reasons why Aphria shares could be headed higher soon.
Is the Right Move to Buy Hexo Stock Amid Cannabis Rebound?
Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.
Cannabis 2.0 Highlights the Rewards — and Risks — of Canopy Growth Stock
Cannabis 2.0 is supposed to give Canopy Growth stock an edge over other cannabis plays. But if Cannabis 2.0 is disappointing, CGC stock will be out of catalysts.
The Outlook of Aurora Stock Is Mixed
Aurora stock is out of favor and is at risk of falling steadily over the next few quarters. But the long-term outlook of ACB stock is upbeat.
A Constellation Buyout Would Harm Canopy Growth Shareholders
Canopy Growth, like other marijuana stocks, continues trending downward. One big factor could prevent it from recovering.
Why Canopy Growth Stock Could Rebound Tremendously in 2020
While 2019 was a rough year for Canopy Growth stock, CGC stock could nearly double in 2020.
Aurora Cannabis Stock Offers Traders Fresh Opportunities
Cannabis stocks are struggling to gain traction but trading opportunities are still available. Aurora stock wants to base to setup rallies.
What the MORE Act Means for Cannabis Stocks
The MORE Act is one of two marijuana bills making their way through Congress. The MORE Act is good news for the legalization effort, but it likely won't be a game-changer for cannabis stocks.
